Stocks and Investing
Stocks and Investing
Wed, October 2, 2024
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
Tue, October 1, 2024
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
Robert Wasserman Reiterated (ANEB) at Buy and Held Target at $8 on, Oct 1st, 2024
Robert Wasserman of Benchmark, Reiterated "Anebulo Pharmaceuticals, Inc." (ANEB) at Buy and Held Target at $8 on, Oct 1st, 2024.
Robert, nor any peers, have made any analyst calls on ANEB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources